Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
Drug and Alcohol Dependence
|
October 18, 2017
Effects of lorcaserin (Belviq<sup>®</sup>) on nicotine- and food-maintained responding in non-human primates
David S Jacobs, Claire E Barkin, Michelle R Kohut, et al.
Drug and Alcohol Dependence
|
December 10, 2019
Discrimination learning in oxycodone-treated nonhuman primates
Sarah L Withey, Rachel J Doyle, Erica N Porter, et al.
Translational Psychiatry
|
August 15, 2020
Empirical validation of a touchscreen probabilistic reward task in rats
Brian D Kangas, Lisa M Wooldridge, Oanh T Luc, et al.
Psychopharmacology
|
March 17, 2019
Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates
Brian D Kangas, Rachel J Doyle, Stephen J Kohut, et al.
Behavioural Pharmacology
|
March 15, 2022
Evidence for spontaneous cannabinoid withdrawal in mice
Carol Paronis, Christos Iliopoulos-Tsoutsouvas, Ioannis Papanastasiou, et al.
Physiology & Behavior
|
December 14, 2007
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman, Marcus S Delatte, Carol A Paronis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2018
Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538
Carol A Paronis, Girish R Chopda, Kiran Vemuri, et al.
Experimental and Clinical Psychopharmacology
|
October 4, 2016
Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance
David S Jacobs, Stephen J Kohut, Shan Jiang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 2012
Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs
Rajeev I Desai, Ganesh A Thakur, V Kiran Vemuri, et al.
Biochemical Pharmacology
|
July 12, 2012
Medication discovery for addiction: translating the dopamine D3 receptor hypothesis
Amy Hauck Newman, Brandi L Blaylock, Michael A Nader, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
Drug and Alcohol Dependence
|
October 18, 2017
Effects of lorcaserin (Belviq<sup>®</sup>) on nicotine- and food-maintained responding in non-human primates
David S Jacobs, Claire E Barkin, Michelle R Kohut, et al.
Drug and Alcohol Dependence
|
December 10, 2019
Discrimination learning in oxycodone-treated nonhuman primates
Sarah L Withey, Rachel J Doyle, Erica N Porter, et al.
Translational Psychiatry
|
August 15, 2020
Empirical validation of a touchscreen probabilistic reward task in rats
Brian D Kangas, Lisa M Wooldridge, Oanh T Luc, et al.
Psychopharmacology
|
March 17, 2019
Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates
Brian D Kangas, Rachel J Doyle, Stephen J Kohut, et al.
Behavioural Pharmacology
|
March 15, 2022
Evidence for spontaneous cannabinoid withdrawal in mice
Carol Paronis, Christos Iliopoulos-Tsoutsouvas, Ioannis Papanastasiou, et al.
Physiology & Behavior
|
December 14, 2007
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman, Marcus S Delatte, Carol A Paronis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2018
Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538
Carol A Paronis, Girish R Chopda, Kiran Vemuri, et al.
Experimental and Clinical Psychopharmacology
|
October 4, 2016
Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance
David S Jacobs, Stephen J Kohut, Shan Jiang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 2012
Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs
Rajeev I Desai, Ganesh A Thakur, V Kiran Vemuri, et al.
Biochemical Pharmacology
|
July 12, 2012
Medication discovery for addiction: translating the dopamine D3 receptor hypothesis
Amy Hauck Newman, Brandi L Blaylock, Michael A Nader, et al.
Page
of 13